Search Results - "Xu, Zhenru"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy by Xu, Zhenru, Han, Xu, Ou, Daming, Liu, Ting, Li, Zunxiong, Jiang, Guanmin, Liu, Jing, Zhang, Ji

    Published in Applied microbiology and biotechnology (01-01-2020)
    “…Autophagy is a highly conserved catabolic process and participates in a variety of cellular biological activities. The phosphoinositide 3-kinase (PI3K)/protein…”
    Get full text
    Journal Article
  2. 2

    High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies by Yuan, Shunling, Liu, Zhaoping, Xu, Zhenru, Liu, Jing, Zhang, Ji

    Published in Journal of hematology and oncology (13-07-2020)
    “…High mobility group box 1 (HMGB1) is a nonhistone chromatin-associated protein that has been widely reported to play a pivotal role in the pathogenesis of…”
    Get full text
    Journal Article
  3. 3

    Analysis of ceRNA networks and identification of potential drug targets for drug-resistant leukemia cell K562/ADR by Liu, Zhaoping, Wang, Yanyan, Xu, Zhenru, Yuan, Shunling, Ou, Yanglin, Luo, Zeyu, Wen, Feng, Liu, Jing, Zhang, Ji

    Published in PeerJ (San Francisco, CA) (25-05-2021)
    “…Drug resistance is the main obstacle in the treatment of leukemia. As a member of the competitive endogenous RNA (ceRNA) mechanism, underlying roles of lncRNA…”
    Get full text
    Journal Article
  4. 4

    The miR‐15a/16 gene cluster in human cancer: A systematic review by Liu, Ting, Xu, Zhenru, Ou, Daming, Liu, Jing, Zhang, Ji

    Published in Journal of cellular physiology (01-05-2019)
    “…MicroRNAs (miRNAs) are an important class of endogenous small noncoding single‐stranded RNAs that suppress the expression of their target genes through…”
    Get full text
    Journal Article
  5. 5

    Mechanical and electromagnetic shielding properties of colored Si3N4 ceramics by Xu, Zhenru, Zhu, Xiaotong, Zhang, Shuai, Li, Tongyang, Qiao, Zhuhui

    Published in Ceramics international (01-09-2024)
    “…The inherent brittleness and uniform coloration of Si3N4 materials have traditionally limited their applicability. In this study, colored Si3N4 ceramics were…”
    Get full text
    Journal Article
  6. 6

    Comprehensive study on the mechanical properties of Ti-doped Si3N4 ceramics: Experimental analysis, DFT calculations, and machine learning by Wu, Jing, Xu, Zhenru, Liu, Xunyong, Tang, Huaguo, Li, Tongyang, Qiao, Zhuhui

    Published in Ceramics international (01-05-2024)
    “…This study involved the synthesis of Si3N4 ceramics, focusing on adjusting TiN content and sintering temperatures to enhance mechanical properties. Utilizing…”
    Get full text
    Journal Article
  7. 7

    Introduction of long non-coding RNAs to regulate autophagy-associated therapy resistance in cancer by Wang, Yanyan, Liu, Zhaoping, Xu, Zhenru, Shao, Wenjun, Hu, Dingyu, Zhong, Huiying, Zhang, Ji

    Published in Molecular biology reports (01-11-2022)
    “…Autophagy is a lysosomal degradation pathway that depends on various evolutionarily conserved autophagy-related genes (ATGs). Dysregulation of autophagy plays…”
    Get full text
    Journal Article
  8. 8

    p19INK4d inhibits proliferation and enhances imatinib efficacy through BCR-ABL signaling pathway in chronic myeloid leukemia by Kuang, Yijin, Han, Xu, Cao, Pengfei, Xiong, Dehui, Peng, Yuanliang, Liu, Zhaoping, Xu, Zhenru, Liang, Long, Roy, Mridul, Liu, Jing, Nie, Ling, Zhang, Ji

    Published in Blood cells, molecules, & diseases (01-11-2020)
    “…Chronic myeloid leukemia (CML) is a kind of myeloproliferative disorder caused by a constitutively active BCR-ABL tyrosine kinase. Tyrosine kinase inhibitors…”
    Get full text
    Journal Article
  9. 9

    p19 INK4d inhibits proliferation and enhances imatinib efficacy through BCR-ABL signaling pathway in chronic myeloid leukemia by Kuang, Yijin, Han, Xu, Cao, Pengfei, Xiong, Dehui, Peng, Yuanliang, Liu, Zhaoping, Xu, Zhenru, Liang, Long, Roy, Mridul, Liu, Jing, Nie, Ling, Zhang, Ji

    Published in Blood cells, molecules, & diseases (01-11-2020)
    “…Chronic myeloid leukemia (CML) is a kind of myeloproliferative disorder caused by a constitutively active BCR-ABL tyrosine kinase. Tyrosine kinase inhibitors…”
    Get full text
    Journal Article